• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Introduction to 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine (CAS No. 1219957-36-4)

5-Bromo-N-isopropyl-3-methyl-2-pyridinamine, identified by its Chemical Abstracts Service (CAS) number 1219957-36-4, is a significant compound in the realm of pharmaceutical and chemical research. This heterocyclic amine derivative has garnered attention due to its structural complexity and potential biological activities, making it a subject of extensive study in medicinal chemistry and drug discovery.

The molecular structure of 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine consists of a pyridine core substituted with a bromine atom at the 5-position, an N-isopropyl group at the 2-position, and a methyl group at the 3-position. This specific arrangement of functional groups imparts unique chemical and pharmacological properties, which have been explored in various research endeavors.

In recent years, the interest in 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine has surged due to its role as a key intermediate in synthesizing novel therapeutic agents. The bromine substituent, in particular, enhances the compound's reactivity, allowing for further functionalization through cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures essential for developing new drugs.

One of the most compelling aspects of 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine is its potential as a scaffold for drug design. Researchers have leveraged its structural features to develop molecules with targeted biological activities. For instance, derivatives of this compound have been investigated for their antimicrobial and anti-inflammatory properties. The pyridine ring is a common motif in many bioactive molecules, and modifications at specific positions can lead to enhanced efficacy and selectivity.

The N-isopropyl group in 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine contributes to the compound's lipophilicity, which is a critical factor in drug absorption and distribution. By optimizing this moiety, scientists can fine-tune the pharmacokinetic profile of potential drug candidates. Additionally, the methyl group at the 3-position influences the electronic properties of the pyridine ring, affecting its interactions with biological targets.

Recent advancements in computational chemistry have further propelled the study of 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine. Molecular modeling techniques allow researchers to predict how this compound might behave in biological systems, aiding in the design of more effective drugs. These simulations have revealed that subtle changes in the substituents can significantly alter the compound's binding affinity to enzymes and receptors.

Moreover, 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine has been explored as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and dysregulation of these pathways is implicated in various diseases, including cancer. By designing molecules that selectively inhibit specific kinases, researchers aim to develop treatments that target these diseases more effectively.

The bromine atom at the 5-position of 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine serves as a versatile handle for further chemical modifications. It can be displaced by various nucleophiles, enabling the construction of diverse molecular libraries. This flexibility has made it a valuable building block in high-throughput screening campaigns aimed at identifying novel bioactive compounds.

In conclusion, 5-Bromo-N-isopropyl-3-methyl-2-pyridinamine (CAS No. 1219957-36-4) represents a promising compound in pharmaceutical research. Its unique structural features and reactivity make it an ideal candidate for developing new drugs with targeted biological activities. As research continues to uncover its potential, this compound is likely to play an increasingly important role in the discovery and development of innovative therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)